Stay updated on Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.

Latest updates to the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now indicates that no new participants are being recruited and adds guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study to assist users. Additionally, there is a formatting change from Intervention / Treatment to Intervention/Treatment and a new release note indicating Revision: v3.6.0.SummaryDifference0.3%

- Check19 days agoChange DetectedThe page’s footer revision label was updated from v3.5.4 to v3.5.5. This appears to be a minor platform/metadata update and does not alter the study content.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a platform release or update to the study record interface.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page metadata indicates an update to the ClinicalTrials.gov site revision (from v3.5.2 to v3.5.3), with no changes to the underlying study information shown.SummaryDifference0.0%

- Check69 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check83 days agoChange DetectedThe Italy location listing was updated from Padua, Italy, 35128 to Padova, Italy, 35128.SummaryDifference0.0%

Stay in the know with updates to Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.